US 11833217
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 11833217 (Muscle targeting complexes and uses thereof for treating dystrophinopathies) held by Dyne Therapeutics, Inc. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61K47/10, A61K47/549